Toby T. Hecht

2.8k total citations · 1 hit paper
28 papers, 1.8k citations indexed

About

Toby T. Hecht is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Toby T. Hecht has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Toby T. Hecht's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Virology and Viral Diseases (5 papers) and Immunotherapy and Immune Responses (5 papers). Toby T. Hecht is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Virology and Viral Diseases (5 papers) and Immunotherapy and Immune Responses (5 papers). Toby T. Hecht collaborates with scholars based in United States, United Kingdom and Austria. Toby T. Hecht's co-authors include Andrea Stern Ferris, Louis M. Weiner, Sheila A. Prindiville, Ira Mellman, James P. Allison, Lynn M. Matrisian, Olivera J. Finn, Martin A. Cheever, Jaye L. Viner and Donald F. Summers and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Journal of Virology.

In The Last Decade

Toby T. Hecht

28 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

2009 1.1k citations Martin A. Cheever, James P. Allison et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toby T. Hecht United States	14	1.1k	797	782	336	209	28	1.8k
Neil L. Berinstein Canada	29	1.3k 1.2×	1.1k 1.4×	792 1.0×	472 1.4×	247 1.2×	104	2.9k
Ralph Mocikat Germany	21	1.5k 1.4×	825 1.0×	788 1.0×	463 1.4×	124 0.6×	65	2.3k
Silvio Roncella Italy	24	651 0.6×	621 0.8×	524 0.7×	150 0.4×	86 0.4×	87	1.9k
E Tatsumi Japan	21	685 0.6×	612 0.8×	639 0.8×	185 0.6×	86 0.4×	82	1.8k
Robin Parihar United States	22	1.5k 1.4×	1.4k 1.7×	482 0.6×	342 1.0×	197 0.9×	47	2.3k
Christian Franci United States	12	2.0k 1.8×	1.4k 1.8×	1.1k 1.4×	212 0.6×	87 0.4×	12	3.0k
Erika Ritter United States	21	1.4k 1.3×	1.1k 1.4×	722 0.9×	197 0.6×	145 0.7×	38	2.1k
Luis E. Fernández Cuba	31	1.3k 1.2×	544 0.7×	1.1k 1.4×	577 1.7×	85 0.4×	70	2.2k
Gundram Jung Germany	31	1.7k 1.6×	1.4k 1.8×	871 1.1×	729 2.2×	149 0.7×	114	2.9k
Carmel M. Lynch United States	13	406 0.4×	990 1.2×	1.1k 1.4×	403 1.2×	826 4.0×	22	2.5k

Countries citing papers authored by Toby T. Hecht

Since Specialization

Citations

This map shows the geographic impact of Toby T. Hecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby T. Hecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby T. Hecht more than expected).

Fields of papers citing papers by Toby T. Hecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toby T. Hecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby T. Hecht. The network helps show where Toby T. Hecht may publish in the future.

Co-authorship network of co-authors of Toby T. Hecht

This figure shows the co-authorship network connecting the top 25 collaborators of Toby T. Hecht. A scholar is included among the top collaborators of Toby T. Hecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toby T. Hecht. Toby T. Hecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navas, Tony, Kristin Fino, King Leung Fung, et al.. (2019). A multiplex immunofluorescence assay to assess immune checkpoint inhibitor-targeted CD8 activation and tumor colocalization in FFPE tissues.. Journal of Clinical Oncology. 37(15_suppl). 2629–2629. 5 indexed citations

Mason, Llewellyn H., Steven L. Giardina, Toby T. Hecht, John R. Ortaldo, & Bonnie J. Mathieson. (2015). LGL-1: A Nonpolymorphic Antigen Expressed on a Major Population of Mouse Natural Killer Cells. PubMed. 140(12). 33–38. 2 indexed citations

Berns, Anton, Ulrik Ringborg, Julio E. Celis, et al.. (2015). Excellent translational research in oncology: A journey towards novel and more effective anti‐cancer therapies. Molecular Oncology. 10(5). 645–651. 9 indexed citations

Jiang, Hua, Yueqing Xie, Andrew Burnette, et al.. (2012). Purification of clinical-grade disulfide stabilized antibody fragment variable—Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli. Applied Microbiology and Biotechnology. 97(2). 621–632. 13 indexed citations

Bergmann, Lothar, Birge Berns, Angus Dalgleish, et al.. (2010). Investigator-initiated trials of targeted oncology agents: why independent research is at risk?. Annals of Oncology. 21(8). 1573–1578. 14 indexed citations

Cheever, Martin A., James P. Allison, Andrea Stern Ferris, et al.. (2009). The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research. Clinical Cancer Research. 15(17). 5323–5337. 1050 indexed citations breakdown →

Yang, Xiao, et al.. (2006). Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor β antibody (HuMikβ1), and correlation with functional activity using an antigen-transfected murine cell line. Journal of Immunological Methods. 311(1-2). 71–80. 5 indexed citations

Zhu, Jianwei, et al.. (2003). Production and purification of refolded recombinant human IL-7 from inclusion bodies. Protein Expression and Purification. 30(2). 156–166. 25 indexed citations

Mason, Llewellyn H., S L Giardina, Toby T. Hecht, John R. Ortaldo, & Bonnie J. Mathieson. (1988). LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells.. The Journal of Immunology. 140(12). 4403–4412. 66 indexed citations

10.

Titus, J A, et al.. (1987). Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.. The Journal of Immunology. 138(11). 4018–4022. 76 indexed citations

11.

Ostrand‐Rosenberg, Suzanne, et al.. (1986). Teratocarcinoma cell MHC antigen expression is regulated in vitro by a soluble noninterferon factor. Cellular Immunology. 99(2). 453–460. 1 indexed citations

12.

Lippman, Marc E., Karen Huff, R. Jakesz, et al.. (1986). Estrogens Regulate Production of Specific Growth Factors in Hormone‐Dependent Human Breast Cancer. Annals of the New York Academy of Sciences. 464(1). 11–16. 20 indexed citations

13.

Hecht, Toby T., et al.. (1984). A monoclonal antibody to hemoglobin F. Annals of Hematology. 49(3). 203–211. 4 indexed citations

14.

Hecht, Toby T., Dan L. Longo, & Louis A. Matis. (1983). The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.. The Journal of Immunology. 131(3). 1049–1055. 133 indexed citations

15.

Hecht, Toby T. & W E Paul. (1982). Limitation of VSV infection by the host's response to VSV-associated cellular antigens.. The Journal of Immunology. 129(4). 1736–1741. 3 indexed citations

16.

Hecht, Toby T. & W E Paul. (1981). Replication of vesicular stomatitis virus in mouse spleen cells. Infection and Immunity. 32(3). 1014–1023. 4 indexed citations

17.

Hecht, Toby T. & Donald F. Summers. (1976). Interactions of vesicular stomatitis virus with murine cell surface antigens. Journal of Virology. 19(3). 833–845. 41 indexed citations

18.

Hecht, Toby T. & Donald F. Summers. (1974). Newcastle Disease Virus Infection of L Cells. Journal of Virology. 14(1). 162–169. 16 indexed citations

19.

Hecht, Toby T. & Donald F. Summers. (1972). Effect of Vesicular Stomatitis Virus Infection on the Histocompatibility Antigen of L Cells. Journal of Virology. 10(4). 578–585. 59 indexed citations

20.

Hecht, Toby T. & Donald F. Summers. (1970). The effect of phleomycin on poliovirus RNA replication. Virology. 40(3). 441–447. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact